Nath Bio-Genes (NATHBIOGEN) Shareholding Pattern

NSE: NATHBIOGEN • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 45.60%
FII Holding 0.31%
DII Holding 0.01%
Public Holding 34.22%
Total Shareholders 33,550
As of Dec 2025
View the latest shareholding pattern of Nath Bio-Genes (NATHBIOGEN) including promoter, FII, DII, and public holdings. Track NATHBIOGEN ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See NATHBIOGEN investment value)

Nath Bio-Genes (NATHBIOGEN) Shareholding Summary

  • Promoter holding remains unchanged at 45.60% in Dec 2025
  • FII/FPI have decreased holdings from 0.32% to 0.31% in Dec 2025
  • DIIs have decreased holdings from 0.76% to 0.01% in Dec 2025
  • Institutional investors have decreased holdings from 1.08% to 0.32% in Dec 2025
  • Public holding has increased from 33.78% to 34.22% in Dec 2025
  • Number of shareholders decreased from 34,122 to 33,550 in Dec 2025

NATHBIOGEN Quarterly Ownership Changes

Quarter-over-quarter changes for Nath Bio-Genes from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.01%
DII Holding Change
Sept 2025 to Dec 2025
-0.75%
Public Holding Change
Sept 2025 to Dec 2025
+0.44%

Nath Bio-Genes (NATHBIOGEN) Quarterly Shareholding Trends

Visual breakdown of NATHBIOGEN ownership distribution over time. Learn more about NATHBIOGEN earnings multiple.

Promoter
FII
DII
Public
Government

Rising institutional holdings in NATHBIOGEN often correlate with improved fundamentals. Check out NATHBIOGEN financial statements.

Nath Bio-Genes (NATHBIOGEN) Shareholding Data

Download complete NATHBIOGEN ownership data for offline analysis. Discover NATHBIOGEN annual price range.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.60% 0.31% 0.01% 0.00% 34.22% 19.87% 100.01% 33,550
Sept 2025 45.60% 0.32% 0.76% 0.00% 33.78% 19.54% 100.00% 34,122
Jun 2025 45.60% 0.42% 2.25% 0.00% 32.98% 18.76% 100.01% 34,207
Mar 2025 45.60% 0.21% 3.94% 0.00% 31.94% 18.31% 100.00% 34,911
Dec 2024 45.60% 0.19% 4.37% 0.00% 31.75% 18.09% 100.00% 35,056
Sept 2024 45.60% 0.19% 4.37% 0.00% 31.54% 18.31% 100.01% 35,423
Jun 2024 45.60% 0.22% 4.38% 0.00% 32.43% 17.39% 100.02% 35,834
Mar 2024 45.60% 0.27% 4.37% 0.00% 32.25% 17.51% 100.00% 35,132
Dec 2023 45.60% 0.00% 4.37% 0.00% 30.95% 19.08% 100.00% 34,263
Sept 2023 45.60% 0.22% 4.37% 0.00% 30.50% 19.31% 100.00% 34,365
Jun 2023 45.60% 0.00% 4.62% 0.00% 30.37% 19.42% 100.01% 33,502
Mar 2023 45.60% 0.00% 4.62% 0.00% 30.17% 19.62% 100.01% 33,960
Dec 2022 45.60% 0.00% 4.62% 0.00% 30.62% 19.16% 100.00% 34,749
Sept 2022 45.60% 0.00% 4.62% 0.00% 31.61% 18.18% 100.01% 35,470
Jun 2022 41.07% 0.00% 4.62% 0.00% 31.29% 23.02% 100.00% 35,484
Mar 2022 41.05% 0.00% 4.85% 0.00% 29.86% 24.24% 100.00% 35,610
Dec 2021 41.03% 0.00% 7.16% 0.00% 25.79% 26.02% 100.00% 33,926
Sept 2021 41.03% 0.00% 8.44% 0.00% 22.92% 27.61% 100.00% 33,272
Jun 2021 41.03% 0.00% 8.55% 0.00% 21.09% 29.33% 100.00% 31,673
Mar 2021 40.86% 0.00% 8.55% 0.00% 21.19% 29.40% 100.00% 25,630

NATHBIOGEN promoter holding above 50% indicates strong insider confidence. Explore the NATHBIOGEN stock price history for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.60% 0.31% 0.01% 0.00% 34.22% 19.87% 100.01% 33,550
Sept 2025 45.60% 0.32% 0.76% 0.00% 33.78% 19.54% 100.00% 34,122
Jun 2025 45.60% 0.42% 2.25% 0.00% 32.98% 18.76% 100.01% 34,207
Mar 2025 45.60% 0.21% 3.94% 0.00% 31.94% 18.31% 100.00% 34,911
Dec 2024 45.60% 0.19% 4.37% 0.00% 31.75% 18.09% 100.00% 35,056
Sept 2024 45.60% 0.19% 4.37% 0.00% 31.54% 18.31% 100.01% 35,423
Jun 2024 45.60% 0.22% 4.38% 0.00% 32.43% 17.39% 100.02% 35,834
Mar 2024 45.60% 0.27% 4.37% 0.00% 32.25% 17.51% 100.00% 35,132
Dec 2023 45.60% 0.00% 4.37% 0.00% 30.95% 19.08% 100.00% 34,263
Sept 2023 45.60% 0.22% 4.37% 0.00% 30.50% 19.31% 100.00% 34,365
Jun 2023 45.60% 0.00% 4.62% 0.00% 30.37% 19.42% 100.01% 33,502
Mar 2023 45.60% 0.00% 4.62% 0.00% 30.17% 19.62% 100.01% 33,960

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 45.60% 0.31% 0.01% 0.00% 34.22% 19.87% 100.01% 33,550
Dec 2024 45.60% 0.19% 4.37% 0.00% 31.75% 18.09% 100.00% 35,056
Dec 2023 45.60% 0.00% 4.37% 0.00% 30.95% 19.08% 100.00% 34,263
Dec 2022 45.60% 0.00% 4.62% 0.00% 30.62% 19.16% 100.00% 34,749
Dec 2021 41.03% 0.00% 7.16% 0.00% 25.79% 26.02% 100.00% 33,926

Year-over-year trends reveal long-term ownership shifts.

Understanding Nath Bio-Genes (NATHBIOGEN) Shareholding Pattern

Nath Bio-Genes shareholding pattern reveals who owns NATHBIOGEN stock and how ownership changes over time. High promoter stakes in NATHBIOGEN often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your NATHBIOGEN trades. NATHBIOGEN book value

Combine NATHBIOGEN ownership analysis with price movements and financial performance for a complete investment picture. (See Nath Bio-Genes dividend policy)